These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8400273)

  • 1. Bone marrow transplantation for Fanconi anemia using low-dose cyclophosphamide/thoracoabdominal irradiation as conditioning regimen: chimerism study by the polymerase chain reaction.
    Socié G; Gluckman E; Raynal B; Petit T; Landman J; Devergie A; Brison O
    Blood; 1993 Oct; 82(7):2249-56. PubMed ID: 8400273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA.
    Mackinnon S; Barnett L; Bourhis JH; Black P; Heller G; O'Reilly RJ
    Blood; 1992 Dec; 80(12):3235-41. PubMed ID: 1467526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unrelated donor bone marrow transplantation in Fanconi anaemia: the Leiden experience.
    Zwaan CM; Van Weel-Sipman MH; Fibbe WE; Oudshoorn M; Vossen JM
    Bone Marrow Transplant; 1998 Mar; 21(5):447-53. PubMed ID: 9535036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low-dose busulfan and cyclophosphamide as conditioning.
    Torjemane L; Ladeb S; Ben Othman T; Abdelkefi A; Lakhal A; Ben Abdeladhim A
    Pediatr Blood Cancer; 2006 Apr; 46(4):496-500. PubMed ID: 16333862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Children and Adolescents with Fanconi Anemia.
    Bonfim C; Ribeiro L; Nichele S; Loth G; Bitencourt M; Koliski A; Kuwahara C; Fabro AL; Pereira NF; Pilonetto D; Thakar M; Kiem HP; Page K; Fuchs EJ; Eapen M; Pasquini R
    Biol Blood Marrow Transplant; 2017 Feb; 23(2):310-317. PubMed ID: 27832981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation from matched siblings in patients with fanconi anemia utilizing low-dose cyclophosphamide, thoracoabdominal radiation and antithymocyte globulin.
    Ayas M; Solh H; Mustafa MM; Al-Mahr M; Al-Fawaz I; Al-Jefri A; Shalaby L; Al-Nasser A; Al-Sedairy R
    Bone Marrow Transplant; 2001 Jan; 27(2):139-43. PubMed ID: 11281382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow transplantation in Fanconi anemia using matched sibling donors.
    Kohli-Kumar M; Morris C; DeLaat C; Sambrano J; Masterson M; Mueller R; Shahidi NT; Yanik G; Desantes K; Friedman DJ
    Blood; 1994 Sep; 84(6):2050-4. PubMed ID: 8081006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms.
    Suttorp M; Schmitz N; Dreger P; Schaub J; Löffler H
    Leukemia; 1993 May; 7(5):679-87. PubMed ID: 8097800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed engraftment and mixed chimerism after HLA-identical sibling donor BMT in Fanconi anaemia.
    Mital MK; Curtis A; Spencer V; Barge D; Skinner R
    Bone Marrow Transplant; 1999 Jul; 24(2):201-4. PubMed ID: 10455350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly sensitive polymerase chain reaction methods show the frequent survival of residual recipient multipotent progenitors after non-T-cell-depleted bone marrow transplantation.
    Petit T; Raynal B; Socié G; Landman-Parker J; Bourhis JH; Gluckman E; Pico J; Brison O
    Blood; 1994 Nov; 84(10):3575-83. PubMed ID: 7949111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies.
    Spitzer TR; McAfee S; Sackstein R; Colby C; Toh HC; Multani P; Saidman S; Weyouth DW; Preffer F; Poliquin C; Foley A; Cox B; Andrews D; Sachs DH; Sykes M
    Biol Blood Marrow Transplant; 2000; 6(3A):309-20. PubMed ID: 10905768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal conditioning in Fanconi anemia promotes multi-lineage marrow engraftment at 10-fold lower cell doses.
    Haworth KG; Ironside C; Ramirez MA; Weitz S; Beard BC; Schwartz JD; Adair JE; Kiem HP
    J Gene Med; 2018 Oct; 20(10-11):e3050. PubMed ID: 30129972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
    Pelot MR; Pearson DA; Swenson K; Zhao G; Sachs J; Yang YG; Sykes M
    Biol Blood Marrow Transplant; 1999; 5(3):133-43. PubMed ID: 10392959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow transplantation in patients with Fanconi anemia: experience with cyclophosphamide and total body irradiation conditioning regimen.
    Solh H; Rao K; Martins da Cunha AM; Padmos A; Sackey K; Ernst P; Spence D; Clink H
    Pediatr Hematol Oncol; 1997; 14(1):67-72. PubMed ID: 9021815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matched sibling donor stem cell transplantation for Fanconi anemia patients with T-cell somatic mosaicism.
    Yabe M; Shimizu T; Morimoto T; Koike T; Takakura H; Tsukamoto H; Muroi K; Oshima K; Asami K; Takata M; Yamashita T; Kato S; Yabe H
    Pediatr Transplant; 2012 Jun; 16(4):340-5. PubMed ID: 22404423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
    Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR
    Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancer.
    Ringdén O; Söderdahl G; Mattsson J; Uzunel M; Remberger M; Hentschke P; Hägglund H; Sparrelid E; Elmhorn-Rosenborg A; Duraj F; Zetterquist H; Ericzon BG
    Transplantation; 2000 May; 69(10):2043-8. PubMed ID: 10852594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplantation for patients with Fanconi anemia: reduced doses of cyclophosphamide without irradiation as conditioning.
    Medeiros C; Zanis-Neto J; Pasquini R
    Bone Marrow Transplant; 1999 Oct; 24(8):849-52. PubMed ID: 10516695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide promotes engraftment of gene-modified cells in a mouse model of Fanconi anemia without causing cytogenetic abnormalities.
    Adair JE; Zhao X; Chien S; Fang M; Wohlfahrt ME; Trobridge GD; Taylor JA; Beard BC; Kiem HP; Becker PS
    J Mol Med (Berl); 2012 Nov; 90(11):1283-94. PubMed ID: 22660274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.